扫码关注科兴官方微信号“疫苗之益”

扫码关注科兴官方抖音号“疫苗之益”

扫码关注科兴官方视频号“疫苗之益”

Our History
2021

图片关键词
Poliomyelitis Vaccine (Vero Cell),Inactivated, Sabin Strains was marketed

COVID-19 Vaccine (Vero Cell), Inactivated—CoronaVac® was officially listed in the WHO Emergency Use Listing on June 1, 2021

COVID-19 Vaccine CoronaVac® has been approved for emergency use/conditional marketing in dozens of countries, including China, Chile, Turkey, Brazil, Indonesia, Etc.

2020

Varicella Vaccine, Live, was marketed

Quadrivalent Influenza Vaccine was marketed

23-valent Pneumococcal Polysaccharide Vaccine was marketed

Initiated the "Anti-COVID-19 Action" program to R&D Inactivated COVID-19 vaccine, CoronaVac®, which was one of the first vaccines against COVID-19 in China to be approved for emergency use

SINOVAC's fourth vaccine industrial base in Daxing, Beijing was put into use

Sinovac (Singapore) Ltd. was founded


2017
MetInfo enterprise content manager system | MetInfo CMS

Sinovac's Inactivated Hepatitis A vaccine, Healive®, passed and the only passed in China the prequalification assessment by WHO


2016
8.pngMetInfo enterprise content manager system | MetInfo CMS

The world's first class I drug for preventative biological products was marketed- Enterovirus Type 71 Inactivated Vaccine (Vero Cell), Inlive®

2012
7.png

Mumps live Vaccine was marketed

2010
MetInfo enterprise content manager system | MetInfo CMS

Sinovac (Dalian) Vaccine Technology Co., Ltd. was founded

MetInfo enterprise content manager system | MetInfo CMS

Acquired and started to build SINOVAC's third vaccine industrial base in Changping Beijing

2009
2.png

The world's first H1N1 Influenza A Inactivated Vaccine (Split Virion), Inactivated, Panfu.1®, was approved to produce for production and started massive vaccination in China

MetInfo enterprise content manager system | MetInfo CMS

Along of Healive® vaccine exported to Mongolia and Anflu® vaccine exported to the Philippines, SINOVAC opened the international market

MetInfo enterprise content manager system | MetInfo CMS

Sinovac Life Sciences Co., Ltd. was founded
Sinovac Holdings was moved to the NASDAQ Global Select Market

2008
3.png

China's first Pandemic Influenza Vaccine (Inactivated, Adjuvanted), PanFlu®,was approved to be produced for government stockpiling
Sinovac Biotech (Hong Kong) Ltd. was founded.


2007
MetInfo enterprise content manager system | MetInfo CMS

SINOVAC was the first company to join the IFPMA in developing countries

2006
6.png

Anflu®,  inactivated, Influenza Vaccine (Split Virion) was marketed

MetInfo enterprise content manager system | MetInfo CMS
2005
4.pngMetInfo enterprise content manager system | MetInfo CMS

Bilive®, China's first and the world's second Hepatitis A and Hepatitis B Combined Vaccine was marketed

2004
MetInfo enterprise content manager system | MetInfo CMS

The world's first SARS inactivated vaccine Phase I clinical study results was unblinded

MetInfo enterprise content manager system | MetInfo CMS

Started study on pandemic influenza vaccine against human infection with highly pathogenic avian influenza (H5N1)
SINOVAC shares were listed on the American Stock Exchange (AMEX)


2003
MetInfo enterprise content manager system | MetInfo CMS

Started the development of an inactivated SARS Vaccine R&D program

Sinovac Holdings was listed on NASDAQ OTCBB in the United States through a reverse takeover


2002
1.pngMetInfo enterprise content manager system | MetInfo CMSMetInfo enterprise content manager system | MetInfo CMS

China's first inactivated Hepatitis A vaccine, Healive®, was marketed


2001
MetInfo enterprise content manager system | MetInfo CMS

Sinovac Biotech Co., Ltd. was founded


1999
MetInfo enterprise content manager system | MetInfo CMSMetInfo enterprise content manager system | MetInfo CMS

A "new drug certificate" was obtained for the inactivated Hepatitis A vaccine


1996
MetInfo enterprise content manager system | MetInfo CMS

Cooperated with the National Institute for the Control of Pharmaceutical and Biological Products to initiate the development of an inactivated Hepatitis A vaccine


1987
MetInfo enterprise content manager system | MetInfo CMS

Developed China's first Hepatitis A enzyme-linked diagnostic reagent

1985
MetInfo enterprise content manager system | MetInfo CMSMetInfo enterprise content manager system | MetInfo CMS

Successfully isolated the TZ84 strain of the hepatitis A virus

1982

Conducted an investigation into endemic areas with endemic hepatitis A